Multicenter Study to Evaluate the Safety and Efficacy of SYMVESS™ in a Real World Setting in Patients With Extremity Arterial Injury Requiring Urgent Repair

计划入组 125 人 · 首次发布于 2026 年 8 月 13 日

A Predictive Technology for Prevention of Diabetic Foot Ulcers

计划入组 45 人 · 首次发布于 2021 年 2 月 24 日

Pediatric Vascular Trauma

计划入组 75 人 · 首次发布于 2025 年 2 月 21 日

vascular agents

Stromal Vascular Fraction

Endoarterial Biopsy Catheter therapy (Vascular Biosciences)

EXTREMITY MEDICAL

Lebanon

Stryker Trauma GmbH

Germany

BRAIN TRAUMA FOUNDATION

United States

Humacyte Secures $60 Million in Oversubscribed Offering to Advance Bioengineered Tissue Platform

Humacyte Advances Bioengineered Vessel Technology Following FDA Approval for Vascular Trauma

Humacyte's Bioengineered Vessel SYMVESS Receives FDA Approval for Extremity Vascular Trauma